AnaptysBio Inc buy Guggenheim
Start price
21.10.24
/
50%
€32.80
Target price
21.10.25
€83.18
Performance (%)
-12.20%
End price
22.10.25
€28.80
Summary
This prediction ended on 22.10.25 with a price of €28.80. The price of AnaptysBio Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -12.20%. Guggenheim has a follow-up prediction for AnaptysBio Inc where he still thinks AnaptysBio Inc is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AnaptysBio Inc | 3.825% | 3.825% | 175.362% |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target raised by analysts at Guggenheim from $75.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten